Ribosomal translation machinery (null)

The ribosomal translation machinery is a collection of macromolecules—including *ribosomes* (complexes of ribosomal RNAs and proteins), transfer RNAs, aminoacyl-tRNA synthetases, and translation factors—that work together to translate genetic information from messenger RNA into polypeptides during protein synthesis[1][2][3][7][8]. This process occurs through coordinated phases of initiation, elongation, termination, and ribosome recycling, requiring dynamic interactions between these components, energy in the form of GTP, and precise molecular recognition events. In bacteria, mitochondria, and the cytoplasm of eukaryotes, variations in ribosome structure provide bases for specific drug targeting, while the functional core—catalysis of peptide bond formation by ribosomal RNA—remains conserved. Drugs targeting this machinery mainly act by interfering with ribosome function, tRNA accommodation, or fidelity during translation, making the translation machinery a central target for anti-infective therapeutics and a focus for many disease mechanisms[1][3][5][7][8]. Note: This entry is a composite and *not a specific, singular molecular target*, thus the "is_incorrect" field is marked as true and the use of this term should be refined when mapping to structured database formats. For most purposes, targets within the "ribosomal translation machinery" should be specified by individual ribosomal proteins, rRNAs, or translational GTPases.

Other names

Translation machineryTranslational apparatusProtein synthesis apparatus

Inhibition of tRNA binding or accommodation; Inhibition of peptidyl transferase activity; Prevention of ribosome translocation; Induction of premature chain termination; Inhibition of ribosome assembly